A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)

NCT05268952 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors

Interventions

OTHER: Liquid biopsies
OTHER: Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT)

Sponsor

University Hospital, Antwerp

Collaborators

[object Object]